Insitro Company
A constellation of technologies now allows us to construct, perturb, and observe biological model systems in the laboratory, allowing the generation of biomolecular data at unprecedented breadth and scale. At the same time, the tools of data science and machine learning are now solving problems previously thought to be decades away from solution.
We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.
We aim to combine these technologies to develop a new approach to drug development that might help us cure more people, sooner, and at a much lower cost.
Investors
Technology:
Early drug development
Industry:
Advanced R&D
Headquarters:
USA
Founded Date:
2018
Register and Claim Ownership